Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 6, Issue 11, 2012, Pages

  Calvo Álvarez, Estefania ^a   Guerrero, Nestor Adrian ^b   Álvarez Velilla, Raquel ^a   Prada, Christopher Fernández ^a   Requena, Jose María ^b   Punzón, Carmen ^c   Llamas, Miguel Ángel ^c   Arévalo, Francisco J ^c   Rivas, Luis ^d   Fresno, Manuel ^b,c   Pérez Pertejo, Yolanda ^a   Balaña Fouce, Rafael ^a   Reguera, Rosa M ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Diomune   (Spain)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CHERRY RED FLUORESCENT PROTEIN; MEMBRANE PROTEIN; MILTEFOSINE; PAROMOMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE COURSE; DRUG SCREENING; FEMALE; FLUORESCENCE; IC 50; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PARASITE LOAD; SKIN LEISHMANIASIS; SOUTHERN BLOTTING;

ANIMALS; ANTIPROTOZOAL AGENTS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION; LEISHMANIA MAJOR; LEISHMANIASIS VACCINES; LEISHMANIASIS, CUTANEOUS; LOWER EXTREMITY; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; PARASITE LOAD; RECOMBINANT PROTEINS; STAINING AND LABELING;

EID: 84870750861     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001927     Document Type: Article

References (64)

1. Desjeux P, (2004) Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 27: 305-318.
2. Hutchens M, Luker GD, (2007) Applications of bioluminescence imaging to the study of infectious diseases. Cell Microbiol 9: 2315-2322.
3. Lang T, Lecoeur H, Prina E, (2009) Imaging Leishmania development in their host cells. Trends Parasitol 25: 464-473.
4. Saeij JP, Boyle JP, Grigg ME, Arrizabalaga G, Boothroyd JC, (2005) Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect Immun 73: 695-702.
5. Franke-Fayard B, Waters AP, Janse CJ, (2006) Real-time in vivo imaging of transgenic bioluminescent blood stages of rodent malaria parasites in mice. Nat Protoc 1: 476-485.
6. Ploemen IH, Prudêncio M, Douradinha BG, Ramesar J, Fonager J, et al. (2009) Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging. PLoS One 4: e7881.
7. Lang T, Goyard S, Lebastard M, Milon G, (2005) Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice. Cell Microbiol 7: 383-392.
8. Buckner FS, Wilson AJ, (2005) Colorimetric assay for screening compounds against Leishmania amastigotes grown in macrophages. Am J Trop Med Hyg 72: 600-605.
9. Sereno D, Roy G, Lemesre JL, Papadopoulou B, Ouellette M, (2001) DNA transformation of Leishmania infantum axenic amastigotes and their use in drug screening. Antimicrob Agents Chemother 45: 1168-1173.
10. Lecoeur H, Buffet P, Morizot G, Goyard S, Guigon G, et al. (2007) Optimization of topical therapy for Leishmania major localized cutaneous leishmaniasis using a reliable C57BL/6 model. PLoS Negl Trop Dis 1: e34.
11. Claes F, Vodnala SK, van Reet N, Boucher N, Lunden-Miguel H, et al. (2009) Bioluminescent imaging of Trypanosoma brucei shows preferential testis dissemination, which may hamper drug efficacy in sleeping sickness. PLoS Negl Trop Dis 3: e486.
12. Shaner NC, Steinbach PA, Tsien RY, (2005) A guide to choosing fluorescent proteins. Nat Methods 2: 905-909.
13. Ha DS, Schwarz JK, Turco SJ, Beverley SM, (1996) Use of the green fluorescent protein as a marker in transfected Leishmania. Mol Biochem Parasitol 77: 57-64.
14. Kamau SW, Grimm F, Hehl AB, (2001) Expression of green fluorescent protein as a marker for effects of antileishmanial compounds in vitro. Antimicrob Agents Chemother 45: 3654-3656.
15. Singh N, Dube A, (2004) Short report: fluorescent Leishmania: application to anti-leishmanial drug testing. Am J Trop Med Hyg 71: 400-402.
16. Chan MM, Bulinski JC, Chang KP, Fong D, (2003) A microplate assay for Leishmania amazonensis promastigotes expressing multimeric green fluorescent protein. Parasitol Res 89: 266-271.
17. Okuno T, Goto Y, Matsumoto Y, Otsuka H, Matsumoto Y, (2003) Applications of recombinant Leishmania amazonensis expressing egfp or the β-galactosidase gene for drug screening and histopathological analysis. Exp Anim 52: 109-118.
18. Dube A, Singh N, Sundar S, Singh N, (2005) Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitol Res 96: 216-223.
19. Kram D, Thäle C, Kolodziej H, Kiderlen AF, (2008) Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation. J Immunol Methods 333: 79-88.
20. Singh N, Gupta R, Jaiswal AK, Sundar S, Dube A, (2009) Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. J Antimicrob Chemother 64: 370-374.
21. Bolhassani A, Taheri T, Taslimi Y, Zamanilui S, Zahedifard F, et al. (2011) Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies. Exp Parasitol 127: 637-645.
22. Pulido SA, Muñoz DL, Restrepo AM, Mesa CV, Alzate JF, et al. (2012) Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs. Acta Trop 122: 36-45.
23. Miβlitz A, Mottram JC, Overath P, Aebischer T, (2000) Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes. Mol Biochem Parasitol 107: 251-261.
24. Mehta SR, Huang R, Yang M, Zhang XQ, Kolli B, et al. (2008) Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery. Clin Vaccine Immunol 15: 1764-1770.
25. Millington OR, Myburgh E, Mottram JC, Alexander J, (2010) Imaging of the host/parasite interplay in cutaneous leishmaniasis. Exp Parasitol 126: 310-317.
26. Peters N, Egen J, Secundino N, Debrabant A, Kimblin N, et al. (2008) In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sandflies. Science 321: 970-974.
27. Ribeiro-Gomes F, Peters N, Debrabant A, Sacks DL, (2012) Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-Leishmania response. PLoS Pathog 8: e1002536.
28. Thalhofer CJ, Chen Y, Sudan B, Love-Homan L, Wilson ME, (2011) Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi. Infect Immun 79: 108-117.
29. Lecoeur H, de La Llave E, Osorio Y, Fortéa J, Goyard S, et al. (2010) Sorting of Leishmania-bearing dendritic cells reveals subtle parasite-induced modulation of host-cell gene expression. Microbes Infect 12: 46-54.
30. De Trez C, Magez S, Akira S, Ryffel B, Carlier Y, et al. (2009) iNOS-Producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog 5: e1000494.
31. Sadlova J, Yeo M, Seblova V, Lewis MD, Mauricio I, et al. (2011) Visualisation of Leishmania donovani fluorescent hybrids during early stage development in the sandfly vector. PLoS One 6: e19851.
32. Kimblin N, Peters N, Debrabant A, Secundino N, Egen J, et al. (2008) Quantification of the infectious dose of Leishmania major transmitted to the skin by single sandflies. Proc Nat Acad Sci USA 105: 10125-10130.
33. Graewe S, Retzlaff S, Struck N, Janse CJ, Heussler VT, (2009) Going live: a comparative analysis of the suitability of the RFP derivatives RedStar, mCherry and tdTomato for intravital and in vitro live imaging of Plasmodium parasites. Biotechnol J 4: 895-902.
34. Seefeldt B, Kasper R, Seidel T, Tinnefeld P, Dietz KJ, et al. (2008) Fluorescent proteins for single-molecule fluorescence applications. J Biophotonics 1: 74-82.
35. Carrion J, Folgueira C, Soto M, Fresno M, Requena JM, (2011) Leishmania infantum HSP70-II null mutant as candidate vaccine against leishmaniasis: a preliminary evaluation. Parasit Vectors 4: 150.
36. Folgueira C, Quijada L, Soto M, Abanades DR, Alonso C, et al. (2005) The translational efficiencies of the two Leishmania infantum HSP70 mRNAs, differing in their 3′-untranslated regions, are affected by shifts in the temperature of growth through different mechanisms. J Biol Chem 280: 35172-35183.
37. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22: 1567-1572.
38. Kapler GM, Coburn CM, Beverley SM, (1990) Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol Cell Biol 10: 1084-1094.
39. Späth GF, Beverley SM, (2001) A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99: 97-103.
40. Racoosin EL, Beverley SM, (1997) Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp Parasitol 85: 283-295.
41. Gaur U, Showalter M, Hickerson S, Dalvi R, Turco SJ, et al. (2009) Leishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hosts. Exp Parasitol 122: 182-191.
42. Sacks DL, Perkins PV, (1984) Identification of an infective stage of Leishmania promastigotes. Science 223: 1417-1419.
43. Osorio Y, Travi BL, Renslo AR, Peniche AG, Melby PC, (2011) Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system. PLoS Negl Trop Dis 5: e962.
44. Lima HC, Bleyenberg JA, Titus RG, (1997) A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today 13: 80-82.
45. Dube A, Gupta R, Singh N, (2009) Reporter genes facilitating discovery of drugs targeting protozoan parasites. Trends Parasitol 25: 432-439.
46. Lin MZ, McKeown MR, Ng HL, Aguilera TA, Shaner NC, et al. (2009) Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. Chem Biol 16: 1169-1179.
47. Roy G, Dumas C, Sereno D, Wu Y, Singh AK, et al. (2000) Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 110: 195-206.
48. Singh N, Gupta R, Jaiswal AK, Sundar S, Dube A, (2009) Transgenic Leishmania donovani isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. J Antimicrob Chemother 64: 370-374.
49. Rastrojo A, Aguado B, Carrasco F, Martín D, Crespillo A, et al. (2012) The transcriptome of Leishmania major by deep RNA sequencing: transcript annotation and relative expression levels in the axenic promastigote stage. Nucl Acids Res (submmited).
50. Holzer TR, McMaster WR, Forney JD, (2006) Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana. Mol Biochem Parasitol 146: 198-218.
51. Callahan HL, Portal AC, Devereaux R, Grogl M, (1997) An axenic amastigote system for drug screening. Antimicrob Agents Chemother 41: 818-822.
52. Ravinder, Bhaskar, Gangwar S, Goyal N, (2012) Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds. Curr Microbiol (in press).
53. Rochette A, Raymond F, Corbeil J, Ouellette M, Papadopoulou B, (2009) Whole-genome comparative RNA expression profiling of axenic and intracellular amastigote forms of Leishmania infantum. Mol Biochem Parasitol 165: 32-47.
54. Sereno D, Cordeiro Da Silva A, Mathieu-Daude F, Ouaissi A, (2007) Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitol Int 56: 3-7.
55. Bilbao-Ramos P, Sifontes-Rodríguez S, Dea-Ayuela MA, Bolás-Fernández F, (2012) A fluorometric method for evaluation of pharmacological activity against intracellular Leishmania amastigotes. J Microbiol Methods 89: 8-11.
56. Hsiao CH, Ueno N, Shao JQ, Schroeder KR, Moore KC, et al. (2011) The effects of macrophage source on the mechanism of phagocytosis and intracellular survival of Leishmania. Microbes Infect 13: 1033-1044.
57. Plock A, Sokolowska-Köhler W, Presber W, (2001) Application of flow cytometry and microscopical methods to characterize the effect of herbal drugs on Leishmania spp. Exp Parasitol 97: 141-153.
58. Ashutosh, Gupta S, Ramesh, Sundar S, Goyal N, (2005) Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening. Antimicrob Agents Chemother 49: 3776-3783.
59. Siqueira-Neto JL, Moon S, Jang J, Yang G, Lee C, et al. (2012) An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages. PLoS Negl Trop Dis 6: e1671.
60. De Muylder G, Ang KK, Chen S, Arkin MR, Engel JC, et al. (2011) A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit. PLoS Negl Trop Dis 5: e1253.
61. Balaña-Fouce R, Prada CF, Requena JM, Cushman M, Pommier Y, et al. (2012) Indotecan (LMP400) and AM13-55: Two novel indenoisoquinolines show potential for treating visceral leishmaniasis. Antimicrob Agents Chemother 56: 5264-5270.
62. Thalhofer CJ, Graff JW, Love-Homan L, Hickerson SM, Craft N, et al. (2010) In vivo imaging of transgenic Leishmania parasites in a live host. J Vis Exp 41: pii 1980.
63. Lecoeur H, Buffet PA, Milon G, Lang T, (2010) Early curative applications of the aminoglycoside WR279396 on an experimental Leishmania major-loaded cutaneous site do not impair the acquisition of immunity. Antimicrob Agents Chemother 54: 984-990.
64. Latorre-Esteves E, Akilov OE, Rai P, Beverley SM, Hasan T, (2010) Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP. J Biophotonics 3: 328-335.